A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

NCT05359133 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to lack of funding to continue the study.

Conditions

Chemotherapy-induced Neuropathic Pain
Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG: Tetrodotoxin
DRUG: Placebo

Sponsor

Wex Pharmaceuticals Inc.